H. Ganchev

O-104 XYOTAXT™ vs. gemcitabine or vinorelbine for the treatment of performance status (PS) 2 patients with chemotherapy-naïve advanced non-small cell lung cancer (NSCLC): The STELLAR 4 Phase III study

N. Bogdanova, M. O'Brien, A. Sandler, 2005 .

A Phase II, Open-Label, Randomized Study to Assess the Efficacy and Safety of AZD6244 (ARRY-142886) Versus Pemetrexed in Patients with Non-small Cell Lung Cancer Who Have Failed One or Two Prior Chemotherapeutic Regimens

J. Hainsworth, T. Ciuleanu, V. Tzekova, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Efficacy and safety of AZD6244 (ARRY-142886) as second/third-line treatment of patients (pts) with advanced non-small cell lung cancer (NSCLC)

J. Hainsworth, T. Ciuleanu, V. Tzekova, 2008 .